Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like igus announces launch of sixth round of vector awards January 25, 2018 TRACO POWER announces THM 15 family of DC-DC converters July 13, 2018 NewTek Sensor Solutions introduces M-375 Series Miniature AC LVDT July 10, 2018